Pay in 4 interest-free payments of $6.02 Learn more
Ships within 48 hours · Estimated delivery Aug 15 - Aug 20
In a trial of Wegovy injection in adult patients with type 2 diabetes (T2D) and a BMI 27 kg/m 2 , hypoglycemia was reported in more patients treated with Wegovy versus placebo
Baseline (before starting GLP-1 or supplements): 25-hydroxyvitamin D (target: 30-50 ng/mL) Vitamin B12 (target: above 400 pg/mL) Serum iron, ferritin, and TIBC Serum magnesium Serum zinc Complete metabolic panel CBC (to check for anemia) Follow-up testing at 3 and 6 months: Repeat all baseline labs Add: body composition measurement (DEXA scan is gold standard) to track lean mass vs fat mass changes Assess supplement adherence and adjust doses based on results The cost of basic nutritional bloodwork is minimal compared to the cost of undiagnosed deficiencies
12 Continuing Education Units (CEUs) FPTA approved with reciprocal acceptance
The low prevalence of Cushings disease in patients with type 2 diabetes and the high prevalence of type 2 diabetes in the general population, does not justify the recommendation that all type 2 diabetes patients should be screened for hypercortisolism, but it should be borne in mind even in the absence of characteristic signs, symptoms and comorbidities
schedule your consultation today *No guarantee of specific results
However, the threshold varies based on several individual factors including age, baseline skin elasticity, genetics, sun damage history, smoking history, and the speed at which weight was lost
US$ 20.94
US$ 21.58
US$ 21.48
